New Procedure for co-ordinating GCP-Inspections

Recommendation
18-20 November 2025
Heidelberg, Germany
GMP and FDA Compliance in Pharmaceutical Development and IMP Manufacturing
The GCP Inspectors Working Group of the European Medicines Agency (EMA) has finally published the Procedure for coordinating GCP inspections requested by the CHMP (EMA/INS/GCP/55482/2013).
This procedure describes the different steps of the Good Clinical Practice (GCP) inspection process and particularly the interfaces between Member States inspection services and the Committee for Medicinal Products for Human Use (CHMP)/European Medicines Agency (EMA).
It describes the overall process from preparation and adoption of the inspection request, designation of responsibilities within the inspection team up to the writing and circulation of inspection reports.
Related GMP News
03.04.2025Update on the ICH M11 CeSHArP Technical Specification
03.04.2025EU Map to Clinical Trials
03.04.2025EMA Concept Paper on Model Informed Drug Development
20.03.2025End of the Transition Period for Clinical Trials
11.02.2025Final ICH E6(R3) Guideline on GCP released
11.02.2025FDA issues Draft Guidance on Handling Protocol Deviations in Clinical Trials